HYPHENS PHARMA financial statements, including revenue, expenses, profit, and loss

The total revenue of 1J5 for the last semiannual is 99.65 M SGD, and it's 3.93% higher compared to the previous semiannual. The net income of H1 24 is 5.42 M SGD.